Rhabdomyolysis and pancreatitis associated with coadministration of danazol 600 mg/d and lovastatin 40 mg/d

Clinical Therapeutics

Volumn 30, Issue 7, 2008, Pages 1330-1335

  Hsieh, Cheng Yang ^a   Chen, Chih Hung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

danazol; lovastatin; pancreatitis; rhabdomyolysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPRAZOLAM; AMLODIPINE; AMYLASE; ASPARTATE AMINOTRANSFERASE; CALCIUM CARBONATE; CREATINE KINASE; DANAZOL; EZETIMIBE; GLIPIZIDE; LABETALOL; MEVINOLIN; SILYMARIN; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; BEDTIME DOSAGE; BONE MARROW HYPOPLASIA; CASE REPORT; CHRONIC HEPATITIS; COMORBIDITY; DIABETES MELLITUS; DIPLOPIA; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSARTHRIA; DYSLIPIDEMIA; DYSPHAGIA; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INCONTINENCE; INSOMNIA; KIDNEY FAILURE; MYALGIA; PANCREATITIS; PARESTHESIA; QUADRIPLEGIA; RHABDOMYOLYSIS; SENSORY DYSFUNCTION; THROMBOCYTOPENIA;

ANTICHOLESTEREMIC AGENTS; BONE MARROW DISEASES; DANAZOL; DRUG INTERACTIONS; FEMALE; HUMANS; LOVASTATIN; MIDDLE AGED; PANCREATITIS; RHABDOMYOLYSIS; THROMBOCYTOPENIA;

EID: 48549092803     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(08)80058-6     Document Type: Article

References (23)

1. Antons K.A., William C.D., Baker S.K., and Phillips P.S. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 119 (2006) 400-409
2. for the American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. Pasternak R.C., Smith Jr. S.C., Bairey-Merz C.N., et al. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke 33 (2002) 2337-2341
3. for the National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel. Thompson P.D., Clarkson P.M., and Rosenson R.S. An assessment of statin safety by muscle experts. Am J Cardiol. 97 (2006) 69C-76C
4. Cyclomen (danazol) [package insert]. Markham: Sanofi-Synthelabo Canada Inc, November 2000
5. http://www.fda.gov/cder/foi/anda/96/74582_Danazol_Prntlbl.pdf Accessed June 24, 2008
6. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Downs J.R., Clearfield M., Weis S., et al. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
7. for the Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Furberg C.D., Adams Jr. H.P., Applegate W.B., et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 90 (1994) 1679-1687
8. Wortmann R.L., Tipping R.W., Levine J.G., and Melin J.M. Frequency of myopathy in patients receiving lovastatin. Am J Cardiol 95 (2005) 983-985
9. Konishi H., Takenaka A., Minouchi T., and Yamaji A. Impairment of CYP3A4 capacity in patients receiving danazol therapy: Examination on oxidative cortisol metabolism. Horm Metab Res 33 (2001) 628-630
10. Williams D., and Feely J. Pharmacokineticpharmacodynamic drug interaction with HMG-CoA reductase inhibitors. Clin Pharmacokinet 41 (2002) 343-370
11. Neuvonen P.J., Niemi M., and Backman J.T. Drug interactions with lipidlowering drugs: Mechanisms and clinical relevance. Clin Pharmacol Ther 80 (2006) 565-581
12. TP-search: Transporter database
13. http://125.206.112.67/tp-search/index.html Accessed June 24, 2008
14. Dallaire M., and Chamberland M. Severe rhabdomyolysis in a patient receiving lovastatin, danazol, and doxycycline [in French]. CMAJ 150 (1994) 1991-1994
15. Aids to the Examination of the Peripheral Nervous System. Editorial Committee for the Guarantors of Brain (1986), Bailliere Tindall, London, UK
16. Andreou E.R., and Ledger S. Potential drug interaction between simvastatin and danazol causing rhabdomyolysis. Can J Clin Pharmacol 10 (2003) 172-174
17. Abdul-Ghaffar N.U., and el-Sonbaty M.R. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy. J Clin Gastroenterol. 21 (1995) 340-341
18. Wong P.W., Dillard T.A., and Kroenke K. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy. South Med J 91 (1998) 202-205
19. Mevacor (lovastatin) [package insert]. Whitehouse Station, NJ: Merck & Co, Inc. November 2005. C.-Y. Hsieh and C.-H. Chen
20. http://www.fda.gov/cder/foi/label/2001/19643s64lbl.pdf Accessed June 24, 2008
21. Chan G., DiVenuti G., and Miller K. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome. Am J Hematol 71 (2002) 166-171
22. Van Heek M., and Davis H. Pharmacology of ezetimibe. Eur Heart J 4 Suppl J (2002) J5-J8
23. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245